http://orcid.org/0000-0001-9468-4543
Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Almitra Rindiarti, Yasuhiro Okamoto, Shunsuke Nakagawa, Junko Hirose, Yuichi Kodama, Takuro Nishikawa & Yoshifumi Kawano. (2022) Changes in intracellular activation-related gene expression and induction of Akt contribute to acquired resistance toward nelarabine in CCRF-CEM cell line. Leukemia & Lymphoma 63:2, pages 404-415.
Read now
Read now
Nikolas Herold. (2021) Pharmacological strategies to overcome treatment resistance in acute myeloid leukemia: increasing leukemic drug exposure by targeting the resistance factor SAMHD1 and the toxicity factor Top2β. Expert Opinion on Drug Discovery 16:1, pages 7-11.
Read now
Read now
Karthik M. Kodigepalli, Minghua Li, Serena Bonifati, Amanda R. Panfil, Patrick L. Green, Shan-Lu Liu & Li Wu. (2018) SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft mice. Cell Cycle 17:23, pages 2564-2576.
Read now
Read now
Karthik M. Kodigepalli, Serena Bonifati, Nagaraja Tirumuru & Li Wu. (2018) SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis. Cell Cycle 17:9, pages 1124-1137.
Read now
Read now
Articles from other publishers (42)
Lucía Gutiérrez-Chamorro, Eudald Felip, Eva Castellà, Vanessa Quiroga, Ifeanyi Jude Ezeonwumelu, Laura Angelats, Anna Esteve, Laia Perez-Roca, Anna Martínez-Cardús, Pedro Luis Fernandez, Angelica Ferrando-Díez, Anna Pous, Milana Bergamino, Beatriz Cirauqui, Marga Romeo, Iris Teruel, Ricard Mesia, Bonaventura Clotet, Eva Riveira-Muñoz, Mireia Margelí & Ester Ballana. (2023) SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer. Cellular Oncology.
Crossref
Crossref
Richard J. Marrero, Xueyuan Cao, Huiyun Wu, Abdelrahman H. Elsayed, Jeffery M. Klco, Raul C. Ribeiro, Jeffrey E. Rubnitz, Xiaotu Ma, Soheil Meshinchi, Richard Aplenc, E. Anders Kolb, Rhonda E. Ries, Todd A. Alonzo, Stanley B. Pounds & Jatinder K. Lamba. (2023) SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia. Blood Advances 7:11, pages 2538-2550.
Crossref
Crossref
Shiva Shirani-Bidabadi, Aliye Tabatabaee, Nazita Tavazohi, Amirali Hariri, Amir Reza Aref, Ali Zarrabi, Nicolette Casarcia, Anupam Bishayee & Mina Mirian. (2023) CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer. European Journal of Cell Biology 102:2, pages 151299.
Crossref
Crossref
Tao Wang, Ping Liu & Jianmin Yang. (2023) Targeting SAMHD1: To overcome multiple anti-cancer drugs resistance in hematological malignancies. Genes & Diseases 10:3, pages 891-900.
Crossref
Crossref
Sunho An, Tam Thuy Lu Vo, Taekwon Son, Hoon Choi, Jinyoung Kim, Juyeon Lee, Byung Hoon Kim, Misun Choe, Eunyoung Ha, Young-Joon Surh, Kyu-Won Kim & Ji Hae Seo. (2023) SAMHD1-induced endosomal FAK signaling promotes human renal clear cell carcinoma metastasis by activating Rac1-mediated lamellipodia protrusion. Experimental & Molecular Medicine 55:4, pages 779-793.
Crossref
Crossref
Sabina Enlund, Indranil Sinha, Amanda Ramilo Amor, Shahrzad Shirazi Fard, Ekaterina Pokrovskaja Tamm, Qingfei Jiang, Vanessa Lundin, Anna Nilsson & Frida Holm. (2022) Malignant DFFB isoform switching promotes leukemia survival in relapse pediatric T‐cell acute lymphoblastic leukemia. eJHaem 4:1, pages 115-124.
Crossref
Crossref
Thomas Helleday & Sean G. Rudd. (2022) Targeting the DNA damage response and repair in cancer through nucleotide metabolism. Molecular Oncology 16:21, pages 3792-3810.
Crossref
Crossref
Nicole E. Bowen, Adrian Oo & Baek Kim. (2022) Mechanistic Interplay between HIV-1 Reverse Transcriptase Enzyme Kinetics and Host SAMHD1 Protein: Viral Myeloid-Cell Tropism and Genomic Mutagenesis. Viruses 14:8, pages 1622.
Crossref
Crossref
Zhou Zhang, Ping Li & Ping Sun. (2022) Expression of SAMHD1 and its mutation on prognosis of colon cancer. Oncology Letters 24:3.
Crossref
Crossref
Feifei Zhang, Jun Sun, Xiaofeng Tang, Yiping Liang, Quanhui Jiao, Bo Yu, Zhengzai Dai, Xuhui Yuan, Jiayu Li, Jinhua Yan, Zhiping Zhang, Song Fan, Min Wang, Haiyan Hu, Changhua Zhang & Xiao-Bin Lv. (2022) Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML. Cell Death & Disease 13:7.
Crossref
Crossref
Hanying Wang, Xin He, Lei Zhang, Haojie Dong, Feiteng Huang, Jie Xian, Min Li, Wei Chen, Xiyuan Lu, Khyatiben V. Pathak, Wenfeng Huang, Zheng Li, Lianjun Zhang, Le Xuan Truong Nguyen, Lu Yang, Lifeng Feng, David J. Gordon, Jing Zhang, Patrick Pirrotte, Chun-Wei Chen, Amandeep Salhotra, Ya-Huei Kuo, David Horne, Guido Marcucci, David B. Sykes, Stefano Tiziani, Hongchuan Jin, Xian Wang & Ling Li. (2022) Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade. Blood 139:26, pages 3752-3770.
Crossref
Crossref
Kristína Šimoničová, Ľuboš Janotka, Helena Kavcová, Zdena Sulová, Albert Breier & Lucia Messingerova. (2022) Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia. Drug Resistance Updates 61, pages 100805.
Crossref
Crossref
Magali Merrien, Agata M. Wasik, Elin Ljung, Mohammad H. A. Morsy, Joana de Matos Rodrigues, Mattias Carlsten, Georgios Z. Rassidakis, Birger Christensson, Arne Kolstad, Mats Jerkeman, Sara Ek, Nikolas Herold, Björn E. Wahlin & Birgitta Sander. (2021) Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma. Virchows Archiv 480:3, pages 655-666.
Crossref
Crossref
Kerstin Schott, Catharina Majer, Alla Bulashevska, Liam Childs, Mirko H. H. Schmidt, Krishnaraj Rajalingam, Markus Munder & Renate König. (2021) SAMHD1 in cancer: curse or cure?. Journal of Molecular Medicine 100:3, pages 351-372.
Crossref
Crossref
Melanie Walter & Patrick Herr. (2022) Re-Discovery of Pyrimidine Salvage as Target in Cancer Therapy. Cells 11:4, pages 739.
Crossref
Crossref
Eudald Felip, Lucía Gutiérrez-Chamorro, Maica Gómez, Edurne Garcia-Vidal, Margarita Romeo, Teresa Morán, Laura Layos, Laia Pérez-Roca, Eva Riveira-Muñoz, Bonaventura Clotet, Pedro Luis Fernandez, Ricard Mesía, Anna Martínez-Cardús, Ester Ballana & Mireia Margelí. (2022) Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types. Cancers 14:3, pages 641.
Crossref
Crossref
Tatjana Sauerer, Christopher Lischer, Adrian Weich, Carola Berking, Julio Vera & Jan Dörrie. (2021) Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus–Positive MCC Cell Lines. Frontiers in Microbiology 12.
Crossref
Crossref
Tamara Rothenburger, Dominique Thomas, Yannick Schreiber, Paul R. Wratil, Tamara Pflantz, Kirsten Knecht, Katie Digianantonio, Joshua Temple, Constanze Schneider, Hanna-Mari Baldauf, Katie-May McLaughlin, Florian Rothweiler, Berna Bilen, Samira Farmand, Denisa Bojkova, Rui Costa, Nerea Ferreirós, Gerd Geisslinger, Thomas Oellerich, Yong Xiong, Oliver T. Keppler, Mark N. Wass, Martin Michaelis & Jindrich CinatlJrJr. (2021) Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Kumar Sanjiv, José Manuel Calderón-Montaño, Therese M. Pham, Tom Erkers, Viktoriia Tsuber, Ingrid Almlöf, Andreas Höglund, Yaser Heshmati, Brinton Seashore-Ludlow, Akhilesh Nagesh Danda, Helge Gad, Elisee Wiita, Camilla Göktürk, Azita Rasti, Stefanie Friedrich, Anders Centio, Montserrat Estruch, Thea Kristin Våtsveen, Nona Struyf, Torkild Visnes, Martin Scobie, Tobias Koolmeister, Martin Henriksson, Olov Wallner, Teresa Sandvall, Sören Lehmann, Kim Theilgaard-Mönch, Mathew J. Garnett, Päivi Östling, Julian Walfridsson, Thomas Helleday & Ulrika Warpman Berglund. (2021) MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia. Cancer Research 81:22, pages 5733-5744.
Crossref
Crossref
Rina Nishii, Takanori Mizuno, Daniel Rehling, Colton Smith, Brandi L. Clark, Xujie Zhao, Scott A. Brown, Brandon Smart, Takaya Moriyama, Yuji Yamada, Tatsuo Ichinohe, Makoto Onizuka, Yoshiko Atsuta, Lei Yang, Wenjian Yang, Paul G. Thomas, Pål Stenmark, Motohiro Kato & Jun J. Yang. (2021) NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir. Nature Communications 12:1.
Crossref
Crossref
Elizabeth R. MorrisSimone KunzelmannSarah J. CaswellAndrew G. PurkissGeoff KellyIan A. Taylor. (2021)
Probing the Catalytic Mechanism and Inhibition of SAMHD1 Using the Differential Properties of R
p
- and S
p
-dNTPαS Diastereomers
. Biochemistry 60:21, pages 1682-1698.
Crossref
Crossref
Tobias Roider, Xi Wang, Katrin Hüttl, Carsten Müller‐Tidow, Wolfram Klapper, Andreas Rosenwald, James Peter Stewart, David Gonzalez de Castro, Peter Dreger, Olivier Hermine, Hanneke C. Kluin‐Nelemans, Niels Grabe, Martin Dreyling, Christiane Pott, German Ott, Eva Hoster & Sascha Dietrich. (2020)
The impact of
SAMHD1
expression and mutation status in mantle cell lymphoma: An analysis of the
MCL
Younger and Elderly trial
. International Journal of Cancer 148:1, pages 150-160.
Crossref
Crossref
Tamara Rothenburger, Katie-May McLaughlin, Tobias Herold, Constanze Schneider, Thomas Oellerich, Florian Rothweiler, Andrew Feber, Tim R. Fenton, Mark N. Wass, Oliver T. Keppler, Martin Michaelis & Jindrich CinatlJr.Jr.. (2020) SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine. Communications Biology 3:1.
Crossref
Crossref
Elizabeth R. Morris, Sarah J. Caswell, Simone Kunzelmann, Laurence H. Arnold, Andrew G. Purkiss, Geoff Kelly & Ian A. Taylor. (2020) Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis. Nature Communications 11:1.
Crossref
Crossref
Tamara Davenne, Jenny Klintman, Sushma Sharma, Rachel E. Rigby, Henry T.W. Blest, Chiara Cursi, Anne Bridgeman, Bernadeta Dadonaite, Kim De Keersmaecker, Peter Hillmen, Andrei Chabes, Anna Schuh & Jan Rehwinkel. (2020) SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTP. Cell Reports 31:6, pages 107640.
Crossref
Crossref
Si’Ana A. Coggins, Bijan Mahboubi, Raymond F. Schinazi & Baek Kim. (2020) SAMHD1 Functions and Human Diseases. Viruses 12:4, pages 382.
Crossref
Crossref
Marc Castellví, Eudald Felip, Ifeanyi Ezeonwumelu, Roger Badia, Edurne Garcia-Vidal, Maria Pujantell, Lucía Gutiérrez-Chamorro, Iris Teruel, Anna Martínez-Cardús, Bonaventura Clotet, Eva Riveira-Muñoz, Mireia Margelí, José Esté & Ester Ballana. (2020) Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 12:3, pages 713.
Crossref
Crossref
Sean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, Cynthia BJ Paulin, Lakshmi Sandhow, Juliane Kutzner, Ida Hed Myrberg, Sarah S Bunten, Hanna Axelsson, Si Min Zhang, Azita Rasti, Petri Mäkelä, Si'Ana A Coggins, Sijia Tao, Sharda Suman, Rui M Branca, Georgios Mermelekas, Elisée Wiita, Sun Lee, Julian Walfridsson, Raymond F Schinazi, Baek Kim, Janne Lehtiö, Georgios Z Rassidakis, Katja Pokrovskaja Tamm, Ulrika Warpman‐Berglund, Mats Heyman, Dan Grandér, Sören Lehmann, Thomas Lundbäck, Hong Qian, Jan‐Inge Henter, Torsten Schaller, Thomas Helleday & Nikolas Herold. (2020)
Ribonucleotide reductase inhibitors suppress
SAMHD
1 ara‐
CTP
ase activity enhancing cytarabine efficacy
. EMBO Molecular Medicine 12:3.
Crossref
Crossref
Zhou Zhang, Lixia Zheng, Yang Yu, Jinying Wu, Fan Yang, Yingxi Xu, Qiqiang Guo, Xuan Wu, Sunrun Cao, Liu Cao & Xiaoyu Song. (2020) Involvement of SAMHD1 in dNTP homeostasis and the maintenance of genomic integrity and oncotherapy (Review). International Journal of Oncology.
Crossref
Crossref
Huinan Jiang, Chuan Li, Zhuogang Liu & Shengjing Hospital. (2020) Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients. Acta Haematologica 143:1, pages 51-59.
Crossref
Crossref
Catalina M. Perelló-Reus, Albert Català, Liska Caviedes-Cárdenas, Nerea Vega-García, Mireia Camós, Sandra Pérez-Torras & Marçal Pastor-Anglada. (2020) FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia. Pharmacological Research 151, pages 104556.
Crossref
Crossref
Elizabeth R. Morris & Ian A. Taylor. (2019) The missing link: allostery and catalysis in the anti-viral protein SAMHD1. Biochemical Society Transactions 47:4, pages 1013-1027.
Crossref
Crossref
Thomas Oellerich, Constanze Schneider, Dominique Thomas, Kirsten M. Knecht, Olga Buzovetsky, Lars Kaderali, Christoph Schliemann, Hanibal Bohnenberger, Linus Angenendt, Wolfgang Hartmann, Eva Wardelmann, Tamara Rothenburger, Sebastian Mohr, Sebastian Scheich, Federico Comoglio, Anne Wilke, Philipp Ströbel, Hubert Serve, Martin Michaelis, Nerea Ferreirós, Gerd Geisslinger, Yong Xiong, Oliver T. Keppler & Jindrich CinatlJr.Jr.. (2019) Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nature Communications 10:1.
Crossref
Crossref
Matthew G. Rees, Brinton Seashore-Ludlow & Paul A. Clemons. 2019. Systems Chemical Biology. Systems Chemical Biology
233
254
.
Christopher H. Mauney, Fred W. Perrino & Thomas Hollis. (2018) Identification of Inhibitors of the dNTP Triphosphohydrolase SAMHD1 Using a Novel and Direct High-Throughput Assay. Biochemistry 57:47, pages 6624-6636.
Crossref
Crossref
George Z. Rassidakis, Nikolas Herold, Ida Hed Myrberg, Nikolaos Tsesmetzis, Sean G. Rudd, Jan-Inge Henter, Torsten Schaller, Siok-Bian Ng, Wee Joo Chng, Benedict Yan, Chin Hin Ng, Farhad Ravandi, Michael Andreeff, Hagop M. Kantarjian, L. Jeffrey Medeiros, Ioanna Xagoraris & Joseph D. Khoury. (2018) Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens. Blood Cancer Journal 8:11.
Crossref
Crossref
Nikolaos Tsesmetzis, Cynthia Paulin, Sean Rudd & Nikolas Herold. (2018) Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. Cancers 10:7, pages 240.
Crossref
Crossref
Jingsi Yang, Fei Wang, Dan Yang, Ke Zhou, Min Liu, Zengqiang Gao, Peng Liu, Yuhui Dong, Jianjun Zhang & Quansheng Liu. (2018) Structural and biochemical characterization of the yeast HD domain containing protein YGK1 reveals a metal-dependent nucleoside 5ʹ-monophosphatase. Biochemical and Biophysical Research Communications 501:3, pages 674-681.
Crossref
Crossref
Paula Jáuregui & Nathaniel R. Landau. (2018) DNA damage induces a SAMHD1-mediated block to the infection of macrophages by HIV-1. Scientific Reports 8:1.
Crossref
Crossref
Chad R. Irwin, Mary M. Hitt & David H. Evans. (2017) Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses. Frontiers in Oncology 7.
Crossref
Crossref
Nikolas Herold, Sean G. Rudd, Kumar Sanjiv, Juliane Kutzner, Ida Hed Myrberg, Cynthia B.J. Paulin, Thale Kristin Olsen, Thomas Helleday, Jan-Inge Henter & Torsten Schaller. (2017) With me or against me: Tumor suppressor and drug resistance activities of SAMHD1. Experimental Hematology 52, pages 32-39.
Crossref
Crossref
Feifei Zhang, Jun Sun, Xiaofeng Tang, Yiping Liang, Quanhui Jiao, Bo Yu, Zhengzai Dai, Xuhui Yuan, Jiayu Li, Jinhua Yan, Zhiping Zhang, Song Fan, Min Wang, Haiyan Hu, Changhua Zhang & Xiao-Bin Lv. (2021) Stabilization of SAMHD1 by NONO is Crucial for Ara-C Resistance in AML. SSRN Electronic Journal.
Crossref
Crossref